Quest Diagnostics Stock Rating Improves Amid Surging Covid Testing Rates

Quest Diagnostics Stock Rating Improves Amid Surging Covid Testing Rates

Quest Diagnostics saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 93 the day before.